Anavex Life Sciences Corp. - AVXL
About Gravity Analytica
Recent News
- 05.14.2025 - Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
- 05.14.2025 - Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
- 05.13.2025 - Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update
- 05.13.2025 - Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update
- 05.06.2025 - Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025
- 05.06.2025 - Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025
- 05.01.2025 - Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
- 05.01.2025 - Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
- 04.30.2025 - Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
- 04.30.2025 - Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
Recent Filings
- 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 04.30.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.30.2025 - 4 Statement of changes in beneficial ownership of securities
- 04.25.2025 - ARS Annual Report to Security Holders
- 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 04.25.2025 - DEF 14A Other definitive proxy statements